Lung epithelial and endothelial cell death accompanied by
inflammation contributes to
hyperoxia-induced
acute lung injury (ALI). Impaired resolution of ALI can promote and/or perpetuate lung pathogenesis, including
fibrosis. Previously, we have shown that the
transcription factor Nrf2 induces cytoprotective gene expression and confers protection against hyperoxic
lung injury, and that Nrf2-mediated signaling is also crucial for the restoration of lung homeostasis post-injury. Although we have reported that PI3K/AKT signaling is required for Nrf2 activation in lung epithelial cells, significance of the PI3K/AKT-Nrf2 crosstalk during hyperoxic
lung injury and repair remains unclear. Thus, we evaluated this aspect using Nrf2 knockout (Nrf2(-/-)) and wild-type (Nrf2(+/+)) mouse models. Here, we show that pharmacologic inhibition of PI3K/AKT signaling increased
lung inflammation and alveolar permeability in Nrf2(+/+) mice, accompanied by decreased expression of Nrf2-target genes such as Nqo1 and Hmox1. PI3K/AKT inhibition dampened
hyperoxia-stimulated Nqo1 and Hmox1 expression in lung epithelial cells and alveolar macrophages. Contrasting with its protective effects, PI3K/AKT inhibition suppressed
lung inflammation in Nrf2(+/+) mice during post-injury. In Nrf2(-/-) mice exposed to room-air, PI3K/AKT inhibition caused
lung injury and
inflammation, but it did not exaggerate
hyperoxia-induced ALI. During post-injury, PI3K/AKT inhibition did not augment, but rather attenuated,
lung inflammation in Nrf2(-/-) mice. These results suggest that PI3K/AKT-Nrf2 signaling is required to dampen
hyperoxia-induced
lung injury and
inflammation. Paradoxically, the PI3K/AKT pathway promotes
lung inflammation, independent of Nrf2, during post-injury.